GPT and Other metabolic disease: To confirm the effects of MG741 on metabolic disorder markers, we measured fasting blood glucose levels, serum levels of insulin, ALT, AST, leptin, total cholesterol, LDL-cholesterol, HDL-cholesterol, liver weight, and liver triglyceride levels.